These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18246486)

  • 1. Development of bioadhesive amino-pegylated poly(anhydride) nanoparticles designed for oral DNA delivery.
    Yoncheva K; Centelles MN; Irache JM
    J Microencapsul; 2008 Mar; 25(2):82-9. PubMed ID: 18246486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles.
    Yoncheva K; Guembe L; Campanero MA; Irache JM
    Int J Pharm; 2007 Apr; 334(1-2):156-65. PubMed ID: 17118588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated poly(anhydride) nanoparticles for oral delivery of docetaxel.
    Ruiz-Gatón L; Espuelas S; Larrañeta E; Reviakine I; Yate LA; Irache JM
    Eur J Pharm Sci; 2018 Jun; 118():165-175. PubMed ID: 29597043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties.
    Yoncheva K; Lizarraga E; Irache JM
    Eur J Pharm Sci; 2005 Apr; 24(5):411-9. PubMed ID: 15784331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles.
    Porfire AS; Zabaleta V; Gamazo C; Leucuta SE; Irache JM
    Int J Pharm; 2010 May; 390(1):37-44. PubMed ID: 19712734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
    Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
    Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
    Zabaleta V; Ponchel G; Salman H; Agüeros M; Vauthier C; Irache JM
    Eur J Pharm Biopharm; 2012 Aug; 81(3):514-23. PubMed ID: 22516136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity and cell interaction studies of bioadhesive poly(anhydride) nanoparticles for oral antigen/drug delivery.
    Ojer P; Neutsch L; Gabor F; Irache JM; López de Cerain A
    J Biomed Nanotechnol; 2013 Nov; 9(11):1891-903. PubMed ID: 24059088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioadhesive properties of pegylated nanoparticles.
    Yoncheva K; Gómez S; Campanero MA; Gamazo C; Irache JM
    Expert Opin Drug Deliv; 2005 Mar; 2(2):205-18. PubMed ID: 16296748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration.
    Inchaurraga L; Martín-Arbella N; Zabaleta V; Quincoces G; Peñuelas I; Irache JM
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):280-9. PubMed ID: 25541441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of thiolated, PEGylated and POZylated silica nanoparticles and evaluation of their retention on rat intestinal mucosa in vitro.
    Ways TMM; Lau WM; Ng KW; Khutoryanskiy VV
    Eur J Pharm Sci; 2018 Sep; 122():230-238. PubMed ID: 29969667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel.
    Agüeros M; Ruiz-Gatón L; Vauthier C; Bouchemal K; Espuelas S; Ponchel G; Irache JM
    Eur J Pharm Sci; 2009 Nov; 38(4):405-13. PubMed ID: 19765652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delivery of camptothecin using cyclodextrin/poly(anhydride) nanoparticles.
    Huarte J; Espuelas S; Lai Y; He B; Tang J; Irache JM
    Int J Pharm; 2016 Jun; 506(1-2):116-28. PubMed ID: 27102993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles.
    Calleja P; Espuelas S; Vauthier C; Ponchel G; Irache JM
    J Pharm Sci; 2015 Sep; 104(9):2877-86. PubMed ID: 25600579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery.
    Iglesias T; López de Cerain A; Irache JM; Martín-Arbella N; Wilcox M; Pearson J; Azqueta A
    Int J Pharm; 2017 Jan; 517(1-2):67-79. PubMed ID: 27908629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrin/poly(anhydride) nanoparticles as drug carriers for the oral delivery of atovaquone.
    Calvo J; Lavandera JL; Agüeros M; Irache JM
    Biomed Microdevices; 2011 Dec; 13(6):1015-25. PubMed ID: 21773725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles.
    Kaul G; Amiji M
    J Pharm Sci; 2005 Jan; 94(1):184-98. PubMed ID: 15761942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-β-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus.
    Zhang D; Pan X; Wang S; Zhai Y; Guan J; Fu Q; Hao X; Qi W; Wang Y; Lian H; Liu X; Wang Y; Sun Y; He Z; Sun J
    Mol Pharm; 2015 Jul; 12(7):2337-51. PubMed ID: 26024817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different approaches for determination of the attachment degree of polyethylene glycols to poly(anhydride) nanoparticles.
    Yoncheva K; Doytchinova I; Irache JM
    Drug Dev Ind Pharm; 2010 Jun; 36(6):676-80. PubMed ID: 20050730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.